Keith W. Marshall
2018 - Conatus Pharmaceuticals
In 2018, Keith W. Marshall earned a total compensation of $875.1K as Executive Vice President, Chief Operating Officer and Chief Financial Officer at Conatus Pharmaceuticals, a 66% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $137,489 |
|---|---|
| Option Awards | $281,606 |
| Salary | $419,175 |
| Other | $36,869 |
| Total | $875,139 |
Marshall received $419.2K in salary, accounting for 48% of the total pay in 2018.
Marshall also received $137.5K in non-equity incentive plan, $281.6K in option awards and $36.9K in other compensation.
Rankings
In 2018, Keith W. Marshall's compensation ranked 9,799th out of 14,244 executives tracked by ExecPay. In other words, Marshall earned more than 31.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,799 out of 14,244 | 31st |
Division Manufacturing | 3,957 out of 5,765 | 31st |
Major group Chemicals And Allied Products | 1,486 out of 2,128 | 30th |
Industry group Drugs | 1,252 out of 1,817 | 31st |
Industry Pharmaceutical Preparations | 963 out of 1,391 | 31st |
Source: SEC filing on April 30, 2019.
Marshall's colleagues
We found two more compensation records of executives who worked with Keith W. Marshall at Conatus Pharmaceuticals in 2018.